TNF Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 |
EBITDA | -1,861 | -2,784 | -4,908 |
EBIT | -3,722 | -5,569 | -9,817 |
Net Income | -9,565 | -9,800 | -2,363 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,668 | -1,912 | -1,932 |
Cash | 536 | 225 | 2,681 |
Basic Shares | 2,275 | 2,141 | 1,666 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | 0 | 0 | -29 |
EBITDA | -3,999 | -15,282 | -29,280 | -12,122 |
EBIT | -17,123 | -30,565 | -29,298 | -12,152 |
Net Income | -3,999 | -15,197 | -29,889 | -17,580 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,980 | -12,270 | -19,516 | -11,924 |
Cash | 2,681 | 749 | 555 | 18,617 |
Basic Shares | 1,542 | 1,294 | 1,167 | 117 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.10 |
2024-06-30 | -$4.54 |
2024-03-31 | -$5.13 |
2023-12-31 | -$2.93 |
